Literature DB >> 22044971

Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.

Sarah Evans1, Zehra Pamuklar, Jonathan Rosko, Patrick Mahaney, Ning Jiang, Chan Park, Alfonso Torquati.   

Abstract

BACKGROUND: The effects of gastric bypass surgery on the secretion of the anorexigenic gut-derived hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), independent of caloric restriction and due to different dietary macronutrients, is not well characterized. This study examines the effects of a mixed-nutrient or high-fat liquid meal on the postprandial stimulation of GLP-1 and PYY following gastric bypass or equivalent hypocaloric diet.
METHODS: Total PYY and active GLP-1 were measured fasting and at multiple points after standardized mixed-nutrient and high-fat liquid meals in two matched groups of obese subjects. The meal stimulation tests were performed before and 14.6 ± 3.3 days after gastric bypass (GBP, n = 10) and before and after a 7-day hypocaloric liquid diet matching the post-GBP diet (control, n = 10).
RESULTS: Mixed-nutrient and high-fat postprandial GLP-1 levels increased following GBP (mixed-nutrient peak: 85.0 ± 28.6-323 ± 51 pg/ml, P < 0.01; high-fat peak: 81.8 ± 9.6-278 ± 49 pg/ml, P < 0.01), but not after diet (mixed-nutrient peak: 104.4 ± 9.4-114.9 ± 15.8 pg/ml, P = NS; high-fat peak: 118.1 ± 16.4-104.4 ± 10.8 pg/ml, P = NS). The postprandial PYY response also increased after GBP but not diet, though the increase in peak PYY did not reach statistical significance (GBP mixed-nutrient peak: 134.8 ± 26.0-220.7 ± 52.9 pg/ml, P = 0.09; GBP high-fat peak: 142.1 ± 34.6-197.9 ± 12.7 pg/ml, P = 0.07; diet mixed-nutrient peak: 99.8 ± 8.0-101.1 ± 13.3 pg/ml, P = NS; diet high-fat peak: 105.0 ± 8.8-103.1 ± 11.8 pg/ml, P = NS). The postprandial GLP-1 response was not affected by the macronutrient content of the meal. However, following GBP the mixed-nutrient PYY total area under the curve (AUC(0-120)) was significantly greater than the high-fat PYY AUC(0-120) (22,081 ± 5,662 pg/ml min vs. 18,711 ± 1,811 pg/ml min, P = 0.04).
CONCLUSIONS: Following GBP there is an increase in the postprandial stimulation of PYY and GLP-1 that is independent of caloric restriction. The phenomenon of "bariatric surgery-induced anorexia" may be linked to the increased levels after GBP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044971      PMCID: PMC3302936          DOI: 10.1007/s00464-011-2004-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

1.  Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

Authors:  Nicola M Neary; Caroline J Small; Maralyn R Druce; Adrian J Park; Sandra M Ellis; Nina M Semjonous; Catherine L Dakin; Karin Filipsson; Fang Wang; Aysha S Kent; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2005-09-08       Impact factor: 4.736

2.  Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies.

Authors:  A Flint; A Raben; J E Blundell; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  2000-01

Review 3.  Update: NIH consensus conference. Gastrointestinal surgery for severe obesity.

Authors:  R E Brolin
Journal:  Nutrition       Date:  1996-06       Impact factor: 4.008

4.  Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.

Authors:  Tanja C M Adam; Johan Jocken; Margriet S Westerterp-Plantenga
Journal:  Obes Res       Date:  2005-04

Review 5.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

6.  Human distribution and release of a putative new gut hormone, peptide YY.

Authors:  T E Adrian; G L Ferri; A J Bacarese-Hamilton; H S Fuessl; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

7.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

8.  Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

Authors:  Christine Feinle; Ian M Chapman; Judith Wishart; Michael Horowitz
Journal:  Peptides       Date:  2002-08       Impact factor: 3.750

9.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

10.  Attenuated peptide YY release in obese subjects is associated with reduced satiety.

Authors:  C W le Roux; R L Batterham; S J B Aylwin; M Patterson; C M Borg; K J Wynne; A Kent; R P Vincent; J Gardiner; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2005-09-15       Impact factor: 4.736

View more
  15 in total

1.  Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study.

Authors:  Federico Sista; Valentina Abruzzese; Marco Clementi; Sergio Carandina; Gianfranco Amicucci
Journal:  J Gastrointest Surg       Date:  2016-10-13       Impact factor: 3.452

Review 2.  A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.

Authors:  Pichamol Jirapinyo; David X Jin; Taha Qazi; Nitin Mishra; Christopher C Thompson
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

Review 3.  Gastrointestinal hormones and polycystic ovary syndrome.

Authors:  Jing Ma; Tzu Chun Lin; Wei Liu
Journal:  Endocrine       Date:  2014-05-04       Impact factor: 3.633

Review 4.  Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.

Authors:  Ajay Kumar Jain; Carel W le Roux; Puneet Puri; Ali Tavakkoli; Nana Gletsu-Miller; Blandine Laferrère; Richard Kellermayer; John K DiBaise; Robert G Martindale; Bruce M Wolfe
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-02       Impact factor: 4.016

5.  Equivalent Increases in Circulating GLP-1 Following Jejunal Delivery of Intact and Hydrolysed Casein: Relevance to Satiety Induction Following Bariatric Surgery.

Authors:  Carel W le Roux; My Engström; Niclas Björnfot; Lars Fändriks; Neil G Docherty
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 6.  Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature.

Authors:  Timothy E Sweeney; John M Morton
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-12       Impact factor: 3.043

Review 7.  Gut-central nervous system axis is a target for nutritional therapies.

Authors:  Gustavo D Pimentel; Thayana O Micheletti; Fernanda Pace; José C Rosa; Ronaldo V T Santos; Fabio S Lira
Journal:  Nutr J       Date:  2012-04-10       Impact factor: 3.271

8.  Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice.

Authors:  C Gelegen; K Chandarana; A I Choudhury; H Al-Qassab; I M Evans; E E Irvine; C B Hyde; M Claret; F Andreelli; S E Sloan; A B Leiter; D J Withers; R L Batterham
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

9.  Impact of Duodenal-Jejunal Exclusion on Satiety Hormones.

Authors:  Charlotte de Jonge; Sander S Rensen; Froukje J Verdam; Royce P Vincent; Steve R Bloom; Wim A Buurman; Carel W le Roux; Nicole D Bouvy; Jan Willem M Greve
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

10.  Removal of duodenum elicits GLP-1 secretion.

Authors:  Giovanna Muscogiuri; Teresa Mezza; Annamaria Prioletta; Gian Pio Sorice; Gennaro Clemente; Gerardo Sarno; Gennaro Nuzzo; Alfredo Pontecorvi; Jens J Holst; Andrea Giaccari
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.